NAIROBI — In the vast, sun-scorched landscapes of northern Kenya, where healthcare facilities are scarce and roads often impassable, a network of community health volunteers is waging a quiet but critical war against polio. These volunteers, many of them women from the very communities they serve, traverse rugged terrain to collect stool samples from children under five, hunting for traces of the poliovirus before it can spark outbreaks. Their work, part of a broader global effort to eradicate polio, has become a cornerstone of Kenya’s public health strategy, particularly in regions where cross-border movement and low vaccination rates have historically allowed the virus to persist.
The initiative, coordinated by Kenya’s Ministry of Health in partnership with international organizations such as the World Health Organization (WHO) and UNICEF, focuses on high-risk areas near the borders with Somalia and Ethiopia. These regions have long been vulnerable to polio due to their remoteness, limited healthcare infrastructure, and the frequent movement of nomadic populations. By leveraging local knowledge and trust, the program aims to bridge gaps in surveillance and vaccination coverage that traditional healthcare systems struggle to address.
What Happened: A Grassroots Surveillance Network
The program operates through a decentralized model, where trained community health volunteers (CHVs) conduct door-to-door visits in their own villages and neighboring communities. Their primary task is to identify children who may have been exposed to poliovirus, either through symptoms such as paralysis or as part of routine surveillance in high-risk areas. When a potential case is identified, volunteers collect stool samples, which are then transported—often over long distances and difficult terrain—to laboratories for testing.
The process is labor-intensive and logistically challenging. In some cases, samples must be carried by foot, motorcycle, or even donkey to the nearest health facility before being shipped to centralized laboratories in Nairobi or other urban centers. Despite these obstacles, the program has proven effective in detecting vaccine-derived poliovirus (VDPV) strains, which emerge when the weakened live virus in oral polio vaccines mutates and regains its ability to cause disease in under-immunized populations.
In 2025, Kenya reported no cases of wild poliovirus, a significant milestone in the country’s eradication efforts. However, environmental surveillance—testing sewage and other samples for traces of the virus—detected vaccine-derived strains in several regions. These findings underscore the persistent threat posed by polio in areas with low vaccination coverage, where the virus can circulate undetected for months before causing outbreaks.
Why It Matters: Filling Gaps in a Fragile Healthcare System
The success of Kenya’s polio surveillance program highlights both the strengths and vulnerabilities of its public health infrastructure. In remote northern regions, where healthcare facilities are few and far between, the reliance on community volunteers is not just a stopgap measure but a necessity. These volunteers, who often work without pay, provide a critical link between marginalized populations and the formal healthcare system.
Their role extends beyond sample collection. Many volunteers are also tasked with educating families about the importance of vaccination, dispelling myths and misinformation that have contributed to vaccine hesitancy in some communities. Cultural beliefs, distrust of government programs, and misinformation spread through social media have all played a role in undermining vaccination efforts in the past. By speaking the local languages and understanding the customs of the communities they serve, volunteers have been able to build trust and improve vaccination uptake.
The program’s impact is measurable. According to data from Kenya’s Ministry of Health, vaccination coverage in some of the most remote regions has improved by as much as 20% in the past three years, though challenges remain. In 2025, the national polio vaccination coverage rate stood at 87%, below the WHO-recommended threshold of 95% needed to achieve herd immunity. The gaps are most pronounced in northern Kenya, where coverage in some counties remains as low as 60%.
Background and Context: The Global Fight Against Polio
Polio, a highly infectious viral disease that can cause irreversible paralysis, was once a global scourge, affecting hundreds of thousands of children annually. Thanks to a decades-long eradication campaign led by the WHO, UNICEF, Rotary International, and the Bill & Melinda Gates Foundation, the number of cases has plummeted by more than 99% since the late 1980s. In 2020, the African continent was certified free of wild poliovirus, a historic achievement that left only Afghanistan and Pakistan as endemic countries.
However, the emergence of vaccine-derived poliovirus (VDPV) has complicated eradication efforts. VDPV strains arise when the weakened live virus in oral polio vaccines mutates and regains its ability to spread and cause disease. These strains are particularly problematic in areas with low vaccination coverage, where the virus can circulate undetected for extended periods. In 2025, VDPV outbreaks were reported in more than a dozen countries, including Kenya, Somalia, and Yemen, highlighting the ongoing threat posed by the virus.
Kenya’s experience is emblematic of the broader challenges facing polio eradication. While the country has made significant progress in reducing wild poliovirus cases, the persistence of VDPV strains underscores the need for sustained vaccination campaigns and robust surveillance systems. The reliance on community volunteers reflects a growing recognition in global health that local participation is essential to reaching marginalized populations, particularly in regions where healthcare infrastructure is weak.
Competing Claims and Uncertainty: The Sustainability Question
Despite its successes, Kenya’s polio surveillance program faces significant challenges, chief among them its long-term sustainability. The program is heavily dependent on external funding from international donors, including the WHO, UNICEF, and the Global Polio Eradication Initiative (GPEI). While these funds have enabled the training of volunteers and the establishment of laboratory networks, there are concerns about what happens when donor priorities shift or funding dries up.
Volunteers, who form the backbone of the program, often work without pay, relying on small stipends or in-kind support to cover their expenses. This model, while cost-effective, raises ethical questions about the exploitation of unpaid labor in public health. Some health advocates have argued that volunteers should be formally integrated into the healthcare system and compensated for their work, but budget constraints have made this difficult to achieve.
There is also uncertainty about the program’s ability to adapt to evolving threats. The COVID-19 pandemic disrupted vaccination campaigns worldwide, leading to a resurgence of polio in some countries. While Kenya managed to maintain its surveillance efforts during the pandemic, the experience highlighted the fragility of disease eradication programs in the face of global crises. Climate change, conflict, and economic instability could further strain the program’s resources and effectiveness in the coming years.
Another area of contention is the balance between oral polio vaccines (OPV) and inactivated polio vaccines (IPV). OPV, which contains a weakened live virus, is cheaper and easier to administer, making it the preferred choice for mass vaccination campaigns in low-income countries. However, its use carries the risk of VDPV emergence. IPV, which contains a killed virus, does not pose this risk but is more expensive and requires trained healthcare workers to administer. Kenya has introduced IPV into its routine immunization schedule, but OPV remains the primary tool for mass campaigns, particularly in remote areas.
What to Watch Next: The Road Ahead for Polio Eradication
As Kenya and the broader global health community grapple with these challenges, several key developments will shape the future of polio eradication efforts:
1. Funding and Sustainability: The Global Polio Eradication Initiative (GPEI) is set to release its new strategic plan in late 2026, which will outline funding priorities for the next five years. Kenya’s ability to sustain its surveillance and vaccination programs will depend in part on whether donors continue to prioritize polio eradication. Advocates are calling for greater investment in domestic health financing to reduce reliance on external support.
2. Vaccine Innovation: Researchers are working on next-generation polio vaccines that could eliminate the risk of VDPV while remaining affordable and easy to administer. One promising candidate is the novel oral polio vaccine type 2 (nOPV2), which has been genetically modified to reduce the likelihood of mutation. Kenya began using nOPV2 in 2024, and early results have been encouraging, but long-term data is still needed to assess its effectiveness.
3. Integration with Other Health Programs: There is growing recognition that polio eradication efforts should be integrated with broader health initiatives, such as routine immunization, maternal and child health, and disease surveillance. In Kenya, some health officials have proposed merging the polio program with the country’s broader primary healthcare strategy to improve efficiency and sustainability.
4. Cross-Border Collaboration: Polio does not respect national borders, and Kenya’s efforts are closely tied to those of its neighbors. The country is part of the Horn of Africa Polio Outbreak Response, a regional initiative that coordinates surveillance and vaccination campaigns across Kenya, Somalia, Ethiopia, and Djibouti. Strengthening these collaborations will be critical to preventing cross-border transmission.
5. Community Engagement: The success of Kenya’s program hinges on the continued participation of community health volunteers. Efforts to formalize their roles, provide training, and offer compensation could improve retention and effectiveness. However, these measures will require additional funding and political will.
Conclusion: A Model with Lessons for Global Health
Kenya’s polio surveillance program offers a compelling case study in the power of community-driven public health. By leveraging local knowledge, trust, and grassroots networks, the program has managed to reach populations that traditional healthcare systems often overlook. Its successes—including the detection of vaccine-derived strains and the improvement of vaccination coverage—demonstrate the value of investing in local participation as a means of strengthening disease surveillance.
Yet the program’s challenges—funding instability, reliance on unpaid labor, and the persistent threat of VDPV—highlight the fragility of such initiatives. As the world edges closer to eradicating polio, the lessons from Kenya underscore the need for sustained investment, innovation, and collaboration. The fight against polio is not just a medical battle but a test of global solidarity, one that requires addressing the systemic inequities that allow diseases to thrive in the first place.
For now, the volunteers of northern Kenya continue their work, traveling from village to village in search of polio’s hidden trail. Their efforts may not make headlines, but they are a vital part of the final push to rid the world of a disease that has plagued humanity for millennia.
Story synopsis gathered from: [Al Jazeera News](https://www.aljazeera.com/news/2026/7/14/how-kenyan-volunteers-hunt-polios-hidden-trail?traffic_source=rss) — source.
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: Al Jazeera News — source.
